122 related articles for article (PubMed ID: 9656742)
1. [Prevention of neural tube defects. An important health and social problem].
Czochańska J; Lech M
Przegl Lek; 1998; 55(4):174-8. PubMed ID: 9656742
[TBL] [Abstract][Full Text] [Related]
2. [Territorial distribution of neural tube defects in Poland].
Lech M; Mazur J; Sawińska I
Przegl Epidemiol; 1997; 51(1-2):185-92. PubMed ID: 9333850
[TBL] [Abstract][Full Text] [Related]
3. [Prevention using folic acid--a good method for reduction of neural tube defects in Poland].
Lech M
Przegl Lek; 1998; 55(6):334-6. PubMed ID: 9857710
[TBL] [Abstract][Full Text] [Related]
4. Knowledge, use, and education regarding folic acid supplementation: continuation study of women in Colorado who had a pregnancy affected by a neural tube defect.
Rinsky-Eng J; Miller L
Teratology; 2002; 66 Suppl 1():S29-31. PubMed ID: 12239741
[TBL] [Abstract][Full Text] [Related]
5. [Basic principles of evaluation of neural tube defects primary prevention programme].
Mierzejewska E; Brzezinski ZJ; Mazur J
Med Wieku Rozwoj; 2000; 4(4 Suppl 1):129-53. PubMed ID: 11490066
[TBL] [Abstract][Full Text] [Related]
6. Method of weighted proportion of reproductive-aged women taking folic acid supplements to predict a neural tube defect rate decline.
Yang Q; Atkinson M; Erickson JD
Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):959-67. PubMed ID: 14745914
[TBL] [Abstract][Full Text] [Related]
7. [Primary prevention program for neural tube defects in Poland].
Brzeziński Z
Med Wieku Rozwoj; 1999; 3(4):503-8. PubMed ID: 10910675
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of neural tube defects in Israel: the effect of the recommendation for periconceptional folic acid.
Zlotogora J; Amitai Y; Leventhal A
Isr Med Assoc J; 2006 Sep; 8(9):601-4. PubMed ID: 17058407
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of neural tube defects and folic acid knowledge and consumption--Puerto Rico, 1996-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Jan; 57(1):10-3. PubMed ID: 18185495
[TBL] [Abstract][Full Text] [Related]
10. Survival of infants with neural tube defects in the presence of folic acid fortification.
Bol KA; Collins JS; Kirby RS;
Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661
[TBL] [Abstract][Full Text] [Related]
11. [Folic acid protects against neural tube defects. But how many women of reproductive age have been informed about this fact?].
Kihlberg R; Bui TH; Jörgensen C; Söderhjelm L
Lakartidningen; 1999 Apr; 96(16):1961-3. PubMed ID: 10330863
[TBL] [Abstract][Full Text] [Related]
12. [Folic acid supplementation as prophylaxis of neural tube defect in the Lower Silesia region: fact or fiction?].
Bagłaj M; Wojtyłko A
Med Wieku Rozwoj; 2011; 15(4):501-6. PubMed ID: 22516708
[TBL] [Abstract][Full Text] [Related]
13. Folic acid to prevent recurrence of neural tube defects.
Pearson K
J Okla State Med Assoc; 1999 Oct; 92(10):513. PubMed ID: 10528476
[No Abstract] [Full Text] [Related]
14. Neural tube defects: prevalence, etiology and prevention.
Kondo A; Kamihira O; Ozawa H
Int J Urol; 2009 Jan; 16(1):49-57. PubMed ID: 19120526
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence of neural tube defects in births before and after promotion of periconceptional folic acid supplementation].
van der Pal-de Bruin KM; Buitendijk SE; Hirasing RA; den Ouden AL
Ned Tijdschr Geneeskd; 2000 Sep; 144(36):1732-6. PubMed ID: 10992899
[TBL] [Abstract][Full Text] [Related]
16. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid.
Heseker HB; Mason JB; Selhub J; Rosenberg IH; Jacques PF
Br J Nutr; 2009 Jul; 102(2):173-80. PubMed ID: 19079944
[TBL] [Abstract][Full Text] [Related]
17. [Differences in folic-acid policy and the prevalence of neural-tube defects in Europe; recommendations for food fortification in a EUROCAT report].
Meijer WM; de Walle HE
Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2561-4. PubMed ID: 16320666
[TBL] [Abstract][Full Text] [Related]
18. Preventing neural tube defects in Europe: a missed opportunity.
Busby A; Abramsky L; Dolk H; Armstrong B; Addor MC; Anneren G; Armstrong N; Baguette A; Barisic I; Berghold A; Bianca S; Braz P; Calzolari E; Christiansen M; Cocchi G; Daltveit AK; De Walle H; Edwards G; Gatt M; Gener B; Gillerot Y; Gjergja R; Goujard J; Haeusler M; Latos-Bielenska A; McDonnell R; Neville A; Olars B; Portillo I; Ritvanen A; Robert-Gnansia E; Rösch C; Scarano G; Steinbicker V
Reprod Toxicol; 2005; 20(3):393-402. PubMed ID: 15927445
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of a neural tube defect recurrence-prevention program.
Grosse SD; Ouyang L; Collins JS; Green D; Dean JH; Stevenson RE
Am J Prev Med; 2008 Dec; 35(6):572-7. PubMed ID: 18845415
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplements to prevent neural tube defects: trends in East of Ireland 1996-2002.
Ward M; Hutton J; Mc Donnell R; Bachir N; Scallan E; O'Leary M; Hoey J; Doyle A; Delany V; Sayers G
Ir Med J; 2004 Oct; 97(9):274-6. PubMed ID: 15568585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
